Red Cell Partners

Red Cell Partners, established in 2020 and based in Washington, D.C., operates as an accelerator and incubator firm. The company specializes in investing in technology companies that are innovating within the national defense and healthcare sectors. By focusing on these critical areas, Red Cell Partners aims to support the development of technologies that enhance national security and improve healthcare outcomes. Its unique positioning at the intersection of investing and national security allows it to contribute to advancements that are vital for both public safety and health.

Wes Bush

Director

Jeff Sherman

Partner

George Barnes

President, Cyber Practice

13 past transactions

Hunted Labs

Pre Seed Round in 2025
Hunted Labs operates as a software security company. Hunted Labs empower clients against potential attacks by enabling visibility, awareness, and control over their software supply chains.

Claros

Seed Round in 2025
Claros is a power management platform provider that utilizes cutting-edge hardware and software to enhance energy distribution and usage at data centers, thereby boosting compute performance and maximizing efficiency.

Andesite AI

Seed Round in 2025
Andesite AI specializes in enhancing the effectiveness of cyber defense teams through its advanced AI security analytics platform. This platform is designed for both private and public-sector cyber analysts, enabling them to defend against sophisticated threats. By analyzing decentralized data sets at scale, Andesite AI's technology allows users to quickly identify threats and vulnerabilities, prioritize their responses, and allocate resources efficiently. This approach not only improves the overall security posture of organizations but also helps reduce costs associated with cyber defense.

Defcon AI

Seed Round in 2024
Defcon AI is a company that operates in the transportation, logistics, supply chain, and storage sectors. It specializes in the development of AI-driven software that aids businesses in evaluating alternative strategies during transportation disruptions. The company's focus is on creating advanced tools for modeling, simulation, and analysis, which help optimize logistics and mobility decision-making. By leveraging sophisticated AI technology, Defcon AI enables organizations to navigate complex scenarios in transportation planning effectively.

Envisagenics

Series B in 2024
Envisagenics, Inc. is a biotechnology company founded in 2013 and headquartered in Huntington, New York. It specializes in the development of a predictive analytics platform aimed at accelerating the discovery of RNA therapeutics. The company leverages advanced artificial intelligence and machine learning algorithms to analyze transcriptomic data, helping researchers identify and validate potential drug targets. Envisagenics' flagship technology, SpliceCore, is a cloud-based platform that utilizes RNA splicing analytics to predict drug targets and biomarkers, addressing the complexities of biomedical data. Given that over 30 million people in the U.S. suffer from genetic diseases or cancers related to RNA splicing errors, the company's mission is to streamline the development of innovative therapeutic solutions. By providing an in-silico RNA therapeutics discovery platform, Envisagenics enhances the efficiency of drug development processes, reducing time, cost, and risk associated with bringing new therapies to market through partnerships with biopharmaceutical companies.

Andesite AI

Series A in 2024
Andesite AI specializes in enhancing the effectiveness of cyber defense teams through its advanced AI security analytics platform. This platform is designed for both private and public-sector cyber analysts, enabling them to defend against sophisticated threats. By analyzing decentralized data sets at scale, Andesite AI's technology allows users to quickly identify threats and vulnerabilities, prioritize their responses, and allocate resources efficiently. This approach not only improves the overall security posture of organizations but also helps reduce costs associated with cyber defense.

Eyris

Pre Seed Round in 2024
Eyris is a blockchain system that enables data-centric security for both public and commercial companies.

Savoy Life

Pre Seed Round in 2023
Savoy Life is a virtual care solution that facilitates the connection between long-term care operators and residents, ensuring access to high-quality and coordinated healthcare services. The platform leverages artificial intelligence to enhance healthcare delivery, aiming to improve occupancy rates and extend residents' length of stay in care facilities. By streamlining communication and care processes, Savoy Life addresses the needs of both operators and residents, fostering a more efficient and effective healthcare experience.

TARA Mind

Pre Seed Round in 2023
TARA Mind is a public benefit corporation focused on improving access to psychedelic-assisted therapy for individuals with treatment-resistant depression. The company addresses gaps in therapeutic accessibility and affordability for high-risk mental health patients by offering a supplemental employer benefit that facilitates safe and affordable access to these innovative therapies. TARA Mind has established a network of vetted providers across the United States, equipping them with proprietary digital tools that support measurement-based care. This data-driven approach enables value-based reimbursements, allowing employers to provide effective and legal mental health treatment as part of their insurance benefits, ultimately aiming to enhance the well-being of their workforce.

Epirus

Series C in 2022
Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.

Envisagenics

Series A in 2021
Envisagenics, Inc. is a biotechnology company founded in 2013 and headquartered in Huntington, New York. It specializes in the development of a predictive analytics platform aimed at accelerating the discovery of RNA therapeutics. The company leverages advanced artificial intelligence and machine learning algorithms to analyze transcriptomic data, helping researchers identify and validate potential drug targets. Envisagenics' flagship technology, SpliceCore, is a cloud-based platform that utilizes RNA splicing analytics to predict drug targets and biomarkers, addressing the complexities of biomedical data. Given that over 30 million people in the U.S. suffer from genetic diseases or cancers related to RNA splicing errors, the company's mission is to streamline the development of innovative therapeutic solutions. By providing an in-silico RNA therapeutics discovery platform, Envisagenics enhances the efficiency of drug development processes, reducing time, cost, and risk associated with bringing new therapies to market through partnerships with biopharmaceutical companies.

Paravision

Venture Round in 2021
Paravision is a San Francisco-based company that specializes in developing advanced face recognition software, primarily for security device manufacturers, solution providers, systems integrators, and financial services firms. Founded in 2013 and originally known as Ever AI until its rebranding in 2019, Paravision leverages deep learning to create industry-leading Vision AI solutions. The company's technology enhances security and user experience by offering capabilities such as age, gender, emotion, and ethnicity detection, facilitating personalized customer interactions and improved security measures. Paravision's commitment to innovation is evident in its high rankings in various NIST evaluations, where it has demonstrated exceptional performance in face recognition accuracy, security, and convenience across diverse identity-centric applications worldwide. With a focus on modular and scalable solutions, Paravision aims to set new standards in face recognition technology.

RED 6

Venture Round in 2021
RED 6 Inc. is a company specializing in outdoor augmented reality solutions aimed at enhancing air combat training. Founded in 2017 and headquartered in Santa Monica, California, it has developed the Airborne Tactical Augmented Reality System (ATARS). This innovative system allows real pilots in actual aircraft to engage with synthetically generated enemy threats in real time, utilizing augmented reality visors and an AI-driven multiplayer network. The technology also incorporates biometric feedback loops to optimize training experiences. RED 6's solutions are designed to revolutionize military training applications, enabling enhanced readiness and operational effectiveness for armed forces worldwide. In addition to military applications, the technology holds potential for various industries, including entertainment, sports, and medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.